Clinical Trials on Respiratory Aspiration in Austria

Total 2709 results

The Alfred
The Alfred Research Trusts Small Project Grant.; Dr Carey Denholm and Laura...

Completed

Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.

Lower Respiratory Tract Infection | Lung Transplant Infection

Australia
Emergent BioSolutions

Completed

Universal Influenza A Vaccine in Healthy Adults (EBS-UFV-001)

Human Influenza

Australia
Endeavor Biomedicines, Inc.

Completed

A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects

Idiopathic Pulmonary Fibrosis

Australia
McMaster University
National Health and Medical Research Council, Australia; Canadian Institutes...

Completed

Caffeine for Apnea of Prematurity (CAP)

Apnea of Prematurity

Canada, United States, Israel, Australia, Netherlands, United Kingdom, Switzerland, Germany, Sweden
Abbott

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

Influenza

Australia
ALK-Abelló A/S

Terminated

A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber (QUEST)

Allergic Rhinoconjunctivitis

Austria, China
siRNAgen Therapeutics Inc.

Active, not recruiting

The First-in-human Study of SRN-001 in Healthy Participants

Idiopathic Pulmonary Fibrosis

Australia
Medical University of Vienna

Completed

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

Pneumonia | Urinary Tract Infection | Abdominal Infection

Austria
Gmax Biopharm Australia Pty Ltd.
Metaclinical; Syneos Heath

Completed

A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers

Pulmonary Arterial Hypertension

Australia
Medical University of Graz
Medical University Innsbruck; Austrian Science Fund (FWF); AGES

Completed

Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria (SARIVA)

COVID-19

Austria
Lyra Therapeutics

Completed

LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)

Chronic Sinusitis | Chronic Rhinosinusitis (Diagnosis)

Poland, Australia, New Zealand, Austria, Czechia
GlaxoSmithKline

Completed

Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).

Asthma

Australia
Vincerx Pharma, Inc.

Recruiting

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Neoplasms

Australia, United States
Lumen Bioscience, Inc.

Completed

A Study to Determine the Tolerability of Intranasal LMN-301

COVID-19

Australia
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B (PIPET B)

Pandemic Influenza

Australia
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza (PIPET C)

Pandemic Influenza

Australia
Medical University of Graz

Completed

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

Chronic Myeloid Leukemia

Austria
GlaxoSmithKline

Completed

Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses

Infections, Respiratory Tract

Australia
Universitaet Innsbruck
Medical University Innsbruck

Recruiting

Going to Altitude With Anxious-depressive Symptoms (Psychoxie)

Hypoxia | Mental Disorder

Austria
South West Sydney Local Health District

Recruiting

Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients (PROFICIENT)

Sepsis | Acute Respiratory Infection | Postoperative Respiratory Distress

Australia
Invivyd, Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants

COVID-19

Australia
Novartis

Completed

Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity

Allergic Rhinitis

Australia
GlaxoSmithKline

Completed

Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation

Asthma

Australia
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza (PIPET A)

Pandemic Influenza

Australia
Pneuma Pharmaceuticals Incorporated

Terminated

Calfactant for Direct Acute Respiratory Distress Syndrome (CARDS)

Respiratory Distress Syndrome, Adult

Korea, Republic of, United States, Canada, New Zealand, Australia, Israel
Ology Bioservices

Completed

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)

Influenza

Austria, Germany, Poland
phenoMapper, LLC
NIH/NCI - Grant award number: R01CA218357

Recruiting

Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation

Lung Neoplasm

Australia
University of Sydney

Recruiting

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging (MAGIK)

Lung Cancer

Australia
Pharmaxis

Completed

A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device

Healthy | Bronchiectasis

Australia
Medical University of Graz

Completed

Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome

Pulmonary Hypertension | Sjögren Syndrome

Austria
Medical University Innsbruck
TNI Medical AG

Unknown

STIT-2: Evaluation of Safety and Efficacy of Short-time TNI® Treatment in Patients With COPD and Hypercapnia (STIT-2)

COPD | Hypercapnia

Austria, Germany, Switzerland
Sensome

Recruiting

InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology (INSPECT)

Lung Cancer

Australia
AdAlta Limited

Completed

Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers

Interstitial Lung Disease

Australia
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan; Q-Pharm Pty...

Completed

Safety and Blood Level Study of Unit Dose Budesonide (UDB P101)

Asthma

Australia
Medical University of Vienna

Completed

Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy (atropinePEI)

Arrhythmia | Respiratory Arrest

Austria
Merck Sharp & Dohme LLC

Completed

A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)

Chronic Cough

United States, Argentina, Canada, Czechia, Denmark, France, Hungary, Israel, Japan, Korea, Republic of, Peru, Poland, Spain, Taiwan, Turkey, Ukraine, United Kingdom
Octapharma

Completed

Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection

Covid19

Austria, France, Germany, Sweden
Nuvaira, Inc.

Completed

Evaluation of the IPS System for TLD Therapy in Patients With COPD (IPS-II)

Chronic Obstructive Pulmonary Disease (COPD)

France, Austria
Codagenix, Inc

Active, not recruiting

Intramuscular CodaVax-H1N1 in Healthy Adults

Influenza, Human

Australia
GlaxoSmithKline

Completed

Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

Infections, Respiratory Tract

United States
Respirion Pharmaceuticals Pty Ltd

Recruiting

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Pseudomonas Aeruginosa | Cystic Fibrosis Lung | Respiratory Infections, Recurrent, Chronic

United States, Australia
Medtronic Cardiac Rhythm and Heart Failure

Completed

FAST (Fluid Accumulation Status Trial)

Heart Diseases | Congestive Heart Failure | Pulmonary Edema | Dyspnea | Cardiomyopathy

United States, Canada, China
Pulmonx Corporation

Completed

Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System (STAGE)

Emphysema

Netherlands, Germany, Austria
Adjuvance Technologies, Inc.

Terminated

Pertussis Acellular Vaccine Adjuvanted With TQL1055

Pertussis

Australia
Codagenix, Inc

Completed

Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray

Influenza

Australia
Respirio Pty Ltd

Completed

Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

Influenza

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

Asthma | Healthy Participants

Australia
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)

Influenza

Australia
Codagenix, Inc

Completed

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

Influenza

Australia
Seqirus

Completed

A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population

Influenza

Australia

3

Subscribe